本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioAge Labs Inc.

4.13
-0.0700-1.67%
盘后4.130.00000.00%16:19 EDT
成交量:18.13万
成交额:75.63万
市值:1.48亿
市盈率:-0.62
高:4.26
开:4.21
低:4.11
收:4.20
数据加载中...
2025/03/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/20

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/08

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/04

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/30

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/27

重要事件披露

Form 8-K - Current report
2024/09/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/09/25

SEC问询函

Form CORRESP - Correspondence
2024/09/25

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/23

SEC问询函

Form CORRESP - Correspondence
2024/09/23

SEC问询函

Form CORRESP - Correspondence
2024/09/18

SEC问询函

Form CORRESP - Correspondence
2024/09/18

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/13

SEC问询函

Form CORRESP - Correspondence
2024/09/04

SEC问询函

Form CORRESP - Correspondence